Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$894K Buy
+25,281
New +$1.03M ﹤0.01% 1875
2025
Q3
Sell
-4,603
Closed -$240K 2254
2025
Q2
$240K Buy
4,603
+780
+20% +$42.8K ﹤0.01% 2015
2025
Q1
$231K Buy
+3,823
New +$246K ﹤0.01% 1997
2024
Q3
Sell
-232,473
Closed -$16.1M 2001
2024
Q2
$16.1M Buy
232,473
+97,818
+73% +$7.14M 0.04% 503
2024
Q1
$10.8M Buy
+134,655
New +$12M 0.03% 671
2022
Q4
Sell
-16,862
Closed -$1.35M 2026
2022
Q3
$1.35M Buy
+16,862
New +$1.59M 0.01% 1193
2022
Q2
Sell
-56,550
Closed -$6.79M 873
2022
Q1
$8.4M Buy
56,550
+394
+0.7% +$55K 0.03% 677
2021
Q4
$7.96M Sell
56,156
-4,179
-7% -$592K 0.03% 685
2021
Q3
$7.89M Buy
60,335
+1,989
+3% +$260K 0.03% 661
2021
Q2
$8.02M Buy
58,346
+26,849
+85% +$3.68M 0.03% 691
2021
Q1
$4.11M Sell
31,497
-6,825
-18% -$821K 0.02% 789
2020
Q4
$4.29M Buy
38,322
+15,827
+70% +$1.5M 0.02% 894
2020
Q3
$1.77M Buy
22,495
+15,895
+241% +$1.3M 0.01% 1228
2020
Q2
$475K Sell
6,600
-15,963
-71% -$1.11M ﹤0.01% 1461
2020
Q1
$1.29M Sell
22,563
-120,423
-84% -$11.1M 0.01% 1045
2019
Q4
$16M Buy
142,986
+137,462
+2,488% +$14.6M 0.05% 445
2019
Q3
$531K Sell
5,524
-22,133
-80% -$2.08M ﹤0.01% 1563
2019
Q2
$2.37M Sell
27,657
-88,954
-76% -$7.31M 0.01% 1250
2019
Q1
$9.7M Sell
116,611
-22,684
-16% -$1.65M 0.04% 578
2018
Q4
$8.94M Sell
139,295
-112,819
-45% -$7.72M 0.04% 501
2018
Q3
$20M Buy
252,114
+46,483
+23% +$3.6M 0.07% 325
2018
Q2
$15.1M Buy
205,631
+50,803
+33% +$3.45M 0.06% 381
2018
Q1
$9.81M Buy
+154,828
New +$9.24M 0.04% 503

Other funds holding CNMD

Man Group's CNMD Position: Q1 2026 in Review

Man Group opened a new position in CONMED (CNMD) in Q1 2026: 25,281 shares worth $894K. The stake represents ﹤0.01% of the portfolio and ranks #1875 among its holdings. This is a return to the name: Man Group previously reported a position in CNMD as recently as Q2 2025.

Man Group first reported a position in CNMD in Q1 2018 and has held it in 23 quarters since. The position peaked at $20M in Q3 2018. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Man Group held 25,281 shares of CONMED worth $894K as of Q1 2026.
  • CONMED was a new Man Group position in Q1 2026.
  • CONMED made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #1875 holding.
  • Man Group first reported a position in CONMED in Q1 2018 and has held it in 23 quarters since.
  • Man Group's CONMED position peaked at $20M in Q3 2018.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.